Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
15th Feb 2018 7:00 am RNS Bioverativ Collaboration and Licence Agreement
1st Feb 2018 11:28 am RNS Total Voting Rights
23rd Jan 2018 9:45 am RNS £3 million Innovate UK grant
23rd Jan 2018 9:30 am RNS Director Dealings / Market Share Purchase
17th Jan 2018 7:00 am RNS Kymriah receives Priority Review for adult DLBCL
9th Jan 2018 9:54 am RNS BLOCK LISTING RETURN
9th Jan 2018 9:54 am RNS BLOCK LISTING RETURN
3rd Jan 2018 1:33 pm RNS Holding(s) in Company
2nd Jan 2018 9:49 am RNS Total Voting Rights
20th Dec 2017 11:22 am RNS Director Dealings / Market Share Purchase
11th Dec 2017 7:08 am RNS Primary analysis results from JULIET trial
1st Dec 2017 10:16 am RNS Total Voting Rights
23rd Nov 2017 11:29 am RNS Director Dealings / Market Share Purchase
9th Nov 2017 7:00 am RNS OXB to present at Jefferies Healthcare Conference
6th Nov 2017 12:06 pm RNS Holdings in Company
6th Nov 2017 7:37 am RNS CTL019 MAA submission to the EMA
1st Nov 2017 9:19 am RNS Total Voting Rights
31st Oct 2017 4:01 pm RNS Kymriah submitted to FDA for adults with r/r DLBCL
23rd Oct 2017 11:27 am RNS Director Dealings / Market Share Purchase
2nd Oct 2017 11:21 am RNS Total Voting Rights
26th Sep 2017 2:55 pm RNS Director Dealings / Market Share Purchase
26th Sep 2017 9:37 am RNS Long Term Incentive Plan Option Grant
25th Sep 2017 3:05 pm RNS Block listing application
25th Sep 2017 9:46 am RNS Cantor Fitzgerald Healthcare Conference 2017
22nd Sep 2017 12:36 pm RNS Director Dealings
20th Sep 2017 3:25 pm RNS Holding(s) in Company
19th Sep 2017 8:58 am RNS Director Dealings
15th Sep 2017 9:21 am RNS Director/PDMR Shareholding
12th Sep 2017 7:15 am RNS Hardman Research: New advanced therapies era
7th Sep 2017 10:11 am RNS Holdings in Company
5th Sep 2017 11:45 am RNS Director/PDMR Shareholding
5th Sep 2017 11:39 am RNS Director/PDMR Shareholding
5th Sep 2017 7:00 am RNS OXB to Present at Rodman & Renshaw Conference
1st Sep 2017 9:25 am RNS Total Voting Rights
30th Aug 2017 4:34 pm RNS CTL019 receives FDA approval
29th Aug 2017 7:00 am RNS Stuart Paynter starts as new CFO
24th Aug 2017 10:41 am RNS Hardman Research: Ready for CTL019 approval
23rd Aug 2017 10:31 am RNS Director Dealings / Market Share Purchase
22nd Aug 2017 10:35 am RNS Director Dealings / Market Share Sale and Purchase
17th Aug 2017 7:00 am RNS Interim Results
FTSE 100 Latest
Value10,600.53
Change-2.95